OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence
Antoine Caillon, Ernesto L. Schiffrin
Current Hypertension Reports (2016) Vol. 18, Iss. 3
Closed Access | Times Cited: 165

Showing 1-25 of 165 citing articles:

Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Hendrik Bartolomaeus, András Balogh, Mina Yakoub, et al.
Circulation (2019) Vol. 139, Iss. 11, pp. 1407-1421
Open Access | Times Cited: 606

NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension
Hai‐Jian Sun, Xingsheng Ren, Xiao-Qing Xiong, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 10, pp. e3074-e3074
Open Access | Times Cited: 220

Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets
Zenglei Zhang, Lin Zhao, Xingyu Zhou, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 160

Hypertension
Meena S. Madhur, Fernando Elijovich, Matthew R. Alexander, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 908-933
Open Access | Times Cited: 156

Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Jun Ma, Yanan Li, Xiangyu Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 107

γδ T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury
Antoine Caillon, Muhammad Oneeb Rehman Mian, Júlio C Fraulob-Aquino, et al.
Circulation (2017) Vol. 135, Iss. 22, pp. 2155-2162
Open Access | Times Cited: 165

Role of immune cells in hypertension
Antoine Caillon, Pierre Paradis, Ernesto L. Schiffrin
British Journal of Pharmacology (2018) Vol. 176, Iss. 12, pp. 1818-1828
Open Access | Times Cited: 141

NADPH oxidases and vascular remodeling in cardiovascular diseases
Ana B. García‐Redondo, Andrea Aguado, Ana M. Briones, et al.
Pharmacological Research (2016) Vol. 114, pp. 110-120
Closed Access | Times Cited: 125

Hypertension in Obesity and the Impact of Weight Loss
Jordana B. Cohen
Current Cardiology Reports (2017) Vol. 19, Iss. 10
Open Access | Times Cited: 125

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
Yang‐Gyun Kim, Sumi Kim, Kipyo Kim, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1389-1389
Open Access | Times Cited: 124

NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling
Xingsheng Ren, Ying Tong, Li Ling, et al.
Cellular Physiology and Biochemistry (2017) Vol. 44, Iss. 6, pp. 2269-2280
Open Access | Times Cited: 100

Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study
Todd M. Gibson, Zhenghong Li, Daniel M. Green, et al.
Cancer Epidemiology Biomarkers & Prevention (2017) Vol. 26, Iss. 12, pp. 1705-1713
Open Access | Times Cited: 89

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19
Harsh Shah, Md Shahjalal Hossain Khan, Nikhil V. Dhurandhar, et al.
Acta Diabetologica (2021) Vol. 58, Iss. 7, pp. 831-843
Open Access | Times Cited: 70

Hypertension in chronic kidney disease: What lies behind the scene
Omar Z. Ameer
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 55

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
Yingdong Lu, Yang Zhang, Xin Zhao, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 51

Inflammation and hypertension: Underlying mechanisms and emerging understandings
Diana Aboukhater, Bassel Morad, Nadim Nasrallah, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 6, pp. 1148-1159
Closed Access | Times Cited: 34

The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension
Jiaming Xiu, Xueqin Lin, Qiansheng Chen, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 26

Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective
Rinaldo Rodrigues dos Passos, Cintia Vieira dos Santos, Fernanda Priviero, et al.
Hypertension (2024) Vol. 81, Iss. 7, pp. 1411-1423
Closed Access | Times Cited: 15

Mast cells: a novel therapeutic avenue for cardiovascular diseases?
Remo Poto, Gianni Marone, Stephen J. Galli, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 7, pp. 681-698
Open Access | Times Cited: 9

Metabolomic characterization of hypertension and dyslipidemia
Chaofu Ke, Xiaohong Zhu, Yuxia Zhang, et al.
Metabolomics (2018) Vol. 14, Iss. 9
Closed Access | Times Cited: 82

Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension
Natalia Jorgelina Prado, León Ferder, Walter Manucha, et al.
Current Hypertension Reports (2018) Vol. 20, Iss. 5
Closed Access | Times Cited: 79

Protective Role of Kallistatin in Vascular and Organ Injury
Julie Chao, Grant Bledsoe, Lee Chao
Hypertension (2016) Vol. 68, Iss. 3, pp. 533-541
Open Access | Times Cited: 75

The Contribution of Inflammation to the Development of Hypertension Mediated by Increased Arterial Stiffness
Hirofumi Tomiyama, Kazuki Shiina, Chisa Matsumoto‐Nakano, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 7
Open Access | Times Cited: 69

Page 1 - Next Page

Scroll to top